ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
Lancet: 10-20-30 targets to address AMR by 2030
DTR Gram-negative infections: Are new antibiotics making a difference?
Reimbursing for innovative antibiotics / Encouraging updates from the AMR conference
The 37,000-year view: Infections in Eurasia
FDA and EMA regulatory updates / Fireside chat during the 4th AMR Conference
The hunt for oral antibiotics: Beyond Lipinski’s Rule of Five
NIAID workshop: What is a robust PK-PD package?
Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR
Limits on measuring the impact of rapid antimicrobial susceptibility testing (AST)
Draft FDA guidance on anti-infectives for children: It’s (mostly) all about PK and safety
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet







